Cargando…

Epigenetics, c-Myc and Aggressive B-cell Lymphomas

Detalles Bibliográficos
Autores principales:	Zhang, Yizhuo, Zhao, Xiaohong, Tao, Jianguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717787/ https://www.ncbi.nlm.nih.gov/pubmed/23175515

Ejemplares similares

MYC and MiR: vicious circle
por: Zhao, Xiaohong, et al.
Publicado: (2013)

Aggressive B-Cell Lymphomas
por: Naresh, Kikkeri N., et al.
Publicado: (2012)

PB2161: CHARACTERISTICS OF AGGRESSIVE B-CELL LYMPHOMAS WITH MYC REARRANGEMENT
por: Ortuzar Pasalodos, A., et al.
Publicado: (2022)

MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas
por: Wang, Michelle Y., et al.
Publicado: (2021)

Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas
por: Gao, Jing, et al.
Publicado: (2021)

High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
por: Pophali, Priyanka A., et al.
Publicado: (2020)

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management
por: Cai, Qingqing, et al.
Publicado: (2015)

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma
por: Yamashita, Takahisa, et al.
Publicado: (2020)

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)
por: Tisi, Maria Chiara, et al.
Publicado: (2019)

The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects
por: Nguyen, Lynh, et al.
Publicado: (2017)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy
por: de Jonge, A. Vera, et al.
Publicado: (2020)

MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas
por: Aquino, Gabriella, et al.
Publicado: (2013)

c-Myc steers translation in lymphoma
por: Cargnello, Marie, et al.
Publicado: (2019)

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021)

B-cell precursor leukemias with MYC-rearrangement come into the limelight
por: Borkhardt, Arndt, et al.
Publicado: (2022)

KDM4C in germinal center lymphoma: a new piece of the epigenetic puzzle
por: Close, Karina, et al.
Publicado: (2022)

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
por: Li, Weiping, et al.
Publicado: (2019)

Novel Therapies for Aggressive B-Cell Lymphoma
por: Foon, Kenneth A., et al.
Publicado: (2012)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification
por: Miyaoka, Masashi, et al.
Publicado: (2022)

Molecular classification of aggressive B-cell lymphoma
por: Bojarczuk, Kamil, et al.
Publicado: (2019)

De Novo CD5-Positive Primary Gastric Diffuse Large B-Cell Lymphoma Coexpressing MYC and BCL6: Towards a Proper Subset of Double-Hit, Triple-Hit and, Maybe, Quadruple-Hit B-Cell Lymphomas?
por: Roncati, Luca
Publicado: (2018)

Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
por: Murga-Zamalloa, Carlos, et al.
Publicado: (2017)

A digital method to interpret the C-MYC stain in diffuse large B cell lymphoma
por: Balakrishna, Jayalakshmi, et al.
Publicado: (2022)

MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma
por: Gagnon, Marie-France, et al.
Publicado: (2021)

Generation of a Murine Model for c-MYC and BCL2 Co-expression B Cell Lymphomas
por: Cai, Zhenming, et al.
Publicado: (2020)

BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
por: Esteve-Arenys, Anna, et al.
Publicado: (2018)

The epigenetic regulator CTCF modulates BCL6 in lymphoma
por: Batlle-López, Ana, et al.
Publicado: (2015)

Gene Regulation and Epigenetic Remodeling in Murine Embryonic Stem Cells by c-Myc
por: Lin, Chin-Hsing, et al.
Publicado: (2009)

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma
por: Ferreri, Andrés J.M., et al.
Publicado: (2022)

Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma: An Underrecognized Aggressive Lymphoma
por: Morgan, Elizabeth A., et al.
Publicado: (2012)

CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
por: Gregory, G P, et al.
Publicado: (2015)

Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas
por: Cacciatore, Matilde, et al.
Publicado: (2012)

Biological Approaches to Aggressive Cutaneous B-Cell Lymphomas
por: Tadiotto Cicogna, Giulia, et al.
Publicado: (2019)

The International Prognostic Index in aggressive B-cell lymphoma
por: Maurer, Matthew J.
Publicado: (2023)

C-MYC, BCL2 and BCL6 Translocation in B-cell Non-Hodgkin Lymphoma Cases
por: Salam, Dayang Sharyati Datu Abdul, et al.
Publicado: (2020)

Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
por: Kluk, Michael J., et al.
Publicado: (2012)

Cross-talk between Myc and p53 in B-cell lymphomas
por: Yu, Li, et al.
Publicado: (2019)

Glucose- and glutamine-fueled stabilization of C-Myc is required for T-cell proliferation and malignant transformation
por: Gabriel, SS, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vmvpqak6o3e3d67cv1vlrjl23i